Menu
Search
|

Menu

Close
X

Kyowa Hakko Kirin Co Ltd 4151.T (Tokyo Stock Exchange)

2,267.00 JPY
-61.00 (-2.62%)
As of 11:30 AM IST
chart
Previous Close 2,328.00
Open 2,287.00
Volume 1,873,600
3m Avg Volume 1,184,569
Today’s High 2,305.00
Today’s Low 2,246.00
52 Week High 2,371.00
52 Week Low 1,642.00
Shares Outstanding (mil) 576.48
Market Capitalization (mil) 1,129,908.00
Forward P/E 49.76
Dividend (Yield %) 12.50 ( 1.28 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 11 analysts

KEY STATS

Revenue (mm, JPY)
FY17
258,439
FY16
343,019
FY15
364,316
EPS (JPY)
FY17
36.049
FY16
34.085
FY15
54.359
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
49.76
32.90
Price to Sales (TTM)
vs sector
3.28
5.77
Price to Book (MRQ)
vs sector
1.76
5.41
Price to Cash Flow (TTM)
vs sector
20.18
23.42
Total Debt to Equity (MRQ)
vs sector
0.91
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
3.49
14.43
Return on Equity (TTM)
vs sector
3.58
16.13

EXECUTIVE LEADERSHIP

Nobuo Hanai
President, Representative Director, Since 2012
Salary: --
Bonus: --
Hiroyuki Kawai
Executive Vice President, Representative Director, Since 2014
Salary: --
Bonus: --
Hiroshi Sugitani
Managing Executive Officer, Chief Director of Sales, Since 2016
Salary: --
Bonus: --
Yutaka Ohuchi
Managing Executive Officer, Director of Human Resources, Since 2012
Salary: --
Bonus: --
Toshifumi Mikayama
Managing Executive Officer, Director of Overseas Business, Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Room 548
5F, Otemachi Bldg., 1-6-1, Ote-m
CHIYODA-KU   TKY   100-0004

Phone: +813.52057200

Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. It also involved in the contracting, retail and wholesale, and insurance agency businesses. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities.

SPONSORED STORIES